Zanubrutinib in RR-MC @SeattleCCA

Zanubrutinib in RR-MC @SeattleCCA

obr

3 months
1 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Chaitra Ujjani, MD, Associate Professor, @SeattleCCA University of Washington, Fred Hutchinson Cancer Research Center, considers the ideal patient profile for zanubrutinib in relapsed/refractory mantle cell lymphoma (RR-MCL).
Up Next Autoplay